baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

GRIFOLS SA/ ES0171996087 /

5/24/2024 9:05:22 AM	Chg. -0.29	Volume	Bid5:29:21 PM	Ask5:29:21 PM	Market Capitalization	Dividend Y.	P/E Ratio
9.02EUR	-3.16%	0 Turnover: -	-Bid Size: -	-Ask Size: -	7.57 bill.EUR	-	101.82

GlobeNewswire 5/20 GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Adva...

GlobeNewswire 4/18 Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...

GlobeNewswire 4/4 Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...

GlobeNewswire 3/31 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 3/29 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...

GlobeNewswire 3/25 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...

GlobeNewswire 3/23 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 3/22 Johnson Fistel, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investig...

GlobeNewswire 3/20 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...

GlobeNewswire 3/15 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 3/1 GRFS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Grifols S.A. (NASDAQ: GRFS) ...

GlobeNewswire 2/14 Grifols announces positive topline phase 3 fibrinogen clinical trial results

GlobeNewswire 2/12 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

GlobeNewswire 2/11 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 2/8 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

GlobeNewswire 2/2 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 2/2 Grifols S.A.: Company Investigated by the Portnoy Law Firm

GlobeNewswire 2/1 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

GlobeNewswire 1/26 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 1/25 ROSEN, LEADING TRIAL ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class...

GlobeNewswire 1/25 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

GlobeNewswire 1/22 ROSEN, SKILLED INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Clas...

Newsfile Corp 1/19 GRFS INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire...

GlobeNewswire 1/19 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

GlobeNewswire 1/18 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GRIFOLS SA/ ES0171996087 /

If you wish to receive reply to your feedback, please provide your email address.